Get the Stockscreener App
1.17
0.85%
-0.01
After Hours:
1.76
0.59
+50.43%
Biocardia Inc stock is traded at $1.17, with a volume of 53,532.
It is down -0.85% in the last 24 hours and down -17.61% over the past month.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
See More
Previous Close:
$1.18
Open:
$1.2299
24h Volume:
53,532
Relative Volume:
0.69
Market Cap:
$12.42M
Revenue:
$3,000
Net Income/Loss:
$-8.79M
P/E Ratio:
-0.5563
EPS:
-2.1033
Net Cash Flow:
$-8.46M
1W Performance:
-5.65%
1M Performance:
-17.61%
6M Performance:
-32.76%
1Y Performance:
-55.51%
1-Day Range:
$1.17
$1.2299
1-Week Range:
$1.1601
$1.33
52-Week Range:
$1.00
$3.20
Biocardia Inc Stock (BCDA) Company Profile
Name
Biocardia Inc
Sector
Industry
Phone
650-226-0123
Address
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.22 | 3.25B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
8.69 | 536.01M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.32 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.8999 | 277.51M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
46.01 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-16-21 | Downgrade | Dawson James | Buy → Neutral |
Biocardia Inc Stock (BCDA) Latest News
BioCardia submits FDA pre-submission for heart delivery catheter By Investing.com - Investing.com Nigeria
Biocardia files pre-submission for FDA approval of Helix(TM) - marketscreener.com
BioCardia (BCDA) Advances Helix Catheter Approval with FDA Pre-S - GuruFocus
BioCardia submits FDA pre-submission for heart delivery catheter - Investing.com
BioCardia Advances FDA Pathway for Helix Delivery Catheter - TipRanks
BioCardia Submits Pre-Submission to FDA for Helix Transendocardial Delivery Catheter Approval - Quiver Quantitative
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart - marketscreener.com
Catheter to deliver cell and gene therapies to the heart heads to FDA - Stock Titan
Insider Buying: Peter Altman Acquires Additional Shares of BioCa - GuruFocus
BioCardia’s CardiAMP Heart Failure Data Selected for LBCT - TipRanks
BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT) - The Manila Times
BioCardia, Inc. Announces Presentation of CardiAMP HF Trial Data - TradingView
Heart failure cell therapy trial lands late-breaking THT slot for echo data - stocktitan.net
Insider Sell: Will Matador Resources Company benefit from geopolitical trendsDividend Hike & Weekly Momentum Stock Picks - baoquankhu1.vn
Activity Recap: Does BioCardia Inc have consistent dividend growthQuarterly Trade Review & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug Ideas: Whats Sono Tek Corporations historical returnPortfolio Value Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Chipmakers Recap: Should you avoid BioCardia Inc stock right now2025 Earnings Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - Intellectia AI
Altman Peter buys BioCardia (BCDA) shares worth $1,194 By Investing.com - Investing.com Nigeria
Altman Peter buys BioCardia (BCDA) shares worth $1,194 - Investing.com
Trend Review: Is BioCardia Inc. in a long term uptrendWeekly Investment Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
US Stocks Recap: Can BioCardia Inc expand its profit marginsJuly 2025 Big Picture & Weekly Chart Analysis and Guides - baoquankhu1.vn
Swing Trade: Is BioCardia Inc stock forming a triangle patternGap Up & High Accuracy Trade Alerts - baoquankhu1.vn
Can BioCardia Inc. stock deliver surprise earnings beat2025 Buyback Activity & AI Enhanced Trade Execution Alerts - Bộ Nội Vụ
Published on: 2026-01-10 18:46:33 - Улправда
Will BioCardia Inc. (6JU0) stock keep high P E multiplesPortfolio Return Report & Reliable Entry Point Alerts - Улправда
Can BioCardia Inc. stock continue upward trendWeekly Stock Report & AI Optimized Trading Strategy Guides - Улправда
Forecast Cut: Will BioCardia Inc. stock rally after Fed decisionsJuly 2025 Weekly Recap & Daily Entry Point Alerts - ulpravda.ru
Will BioCardia Inc. stock rally after Fed decisionsMarket Activity Report & Community Trade Idea Sharing Platform - Улправда
How BioCardia Inc. stock reacts to bond yields2026 world cup usa national team qualification midfield engines set piece tactics expert forecast analysis - Улправда
Bull Run: Why analysts raise outlook for BioCardia Inc 6JU0 stock2025 Market Outlook & Daily Profit Focused Stock Screening - moha.gov.vn
Profit Review: Will BioCardia Inc 6JU0 stock sustain uptrend momentumJuly 2025 Volume & Safe Capital Growth Stock Tips - moha.gov.vn
Is BioCardia Inc 6JU0 a good long term investmentEconomic Indicators Overview & Free Stay Ahead With Picks - earlytimes.in
BioCardia (BCDA) Stock Analysis Report | Financials & Insights - Benzinga
BioCardia advances CardiAMP therapy in Japan - MSN
Will BioCardia Inc. stock deliver long term returns2025 Technical Patterns & Daily Growth Stock Tips - Улправда
Will BioCardia Inc. stock keep outperforming rivals2025 Winners & Losers & Weekly Top Performers Watchlists - Улправда
Why BioCardia Inc. stock remains on buy lists2025 Winners & Losers & Consistent Income Trade Ideas - Улправда
Is BioCardia Inc. (6JU0) stock prepared for digital transitionTake Profit & Fast Exit Strategy with Risk Control - Улправда
Why retail investors pile into BioCardia Inc. stock2025 Volume Leaders & Reliable Volume Spike Trade Alerts - Улправда
Why BioCardia Inc. (6JU0) stock is trending on social media2025 Technical Patterns & Technical Entry and Exit Tips - Улправда
Is BioCardia Inc. (6JU0) stock protected from inflationJuly 2025 Earnings & Precise Swing Trade Alerts - Улправда
Is BioCardia Inc. stock attractive for ETFsMarket Performance Recap & Daily Price Action Insights - Улправда
BioCardia (BCDA) registers 424,509 incentive plan shares after 2025 vote - Stock Titan
Meme Stocks: Will BioCardia Inc. stock deliver long term returnsJuly 2025 EndofMonth & Verified Entry Point Signals - Улправда
BioCardia first patient enrolled at Henry Ford Health for Phase 3 CardiAMP - MSN
CEO Altman Buys 1,100 ($1.4K) Of BioCardia Inc [BCDA] - TradingView — Track All Markets
BioCardia (BCDA) CEO and president discloses December insider share buys - Stock Titan
BioCardia (BCDA) Advances CardiAMP Therapy for Heart Failure in Japan - GuruFocus
Biocardia cell therapy to enter PMDA clinical consultation - marketscreener.com
BioCardia Advances CardiAMP Therapy in Japan - TipRanks
Biocardia Inc Stock (BCDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):